These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells. Liu J; Livingston MJ; Dong G; Tang C; Su Y; Wu G; Yin XM; Dong Z Cell Death Dis; 2018 Feb; 9(3):322. PubMed ID: 29476062 [TBL] [Abstract][Full Text] [Related]
9. Cumulative DNA damage by repeated low-dose cisplatin injection promotes the transition of acute to chronic kidney injury in mice. Yamashita N; Nakai K; Nakata T; Nakamura I; Kirita Y; Matoba S; Humphreys BD; Tamagaki K; Kusaba T Sci Rep; 2021 Oct; 11(1):20920. PubMed ID: 34686727 [TBL] [Abstract][Full Text] [Related]
10. Moderate aging does not exacerbate cisplatin-induced kidney injury or fibrosis despite altered inflammatory cytokine expression and immune cell infiltration. Sharp CN; Doll M; Dupre TV; Beverly LJ; Siskind LJ Am J Physiol Renal Physiol; 2019 Jan; 316(1):F162-F172. PubMed ID: 30484347 [TBL] [Abstract][Full Text] [Related]
11. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation. Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395 [TBL] [Abstract][Full Text] [Related]
12. PINK1/Parkin-mediated mitophagy is activated in cisplatin nephrotoxicity to protect against kidney injury. Wang Y; Tang C; Cai J; Chen G; Zhang D; Zhang Z; Dong Z Cell Death Dis; 2018 Nov; 9(11):1113. PubMed ID: 30385753 [TBL] [Abstract][Full Text] [Related]
13. Rapamycin Is Not Protective against Ischemic and Cisplatin-Induced Kidney Injury. Andrianova NV; Zorova LD; Babenko VA; Pevzner IB; Popkov VA; Silachev DN; Plotnikov EY; Zorov DB Biochemistry (Mosc); 2019 Dec; 84(12):1502-1512. PubMed ID: 31870254 [TBL] [Abstract][Full Text] [Related]